Status:
TERMINATED
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
COPD
Cystic Fibrosis
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.
Detailed Description
Current pulmonary imaging techniques are clinically regulated to machines that produce radiation. MR which does not produce radiation was not possible due to the low concentration of fluids in the ope...
Eligibility Criteria
Inclusion
- Are male or female and are 5 years or older
- Consent/assent from the patient
- Have been diagnosed with a pulmonary disease such as COPD, Asthma, or cystic fibrosis. OR Healthy Individuals.
- Must be able to hold their breath for up to 15 seconds
Exclusion
- Have any contraindications to an MR exam such as a pace-maker, metallic cardiac valves, magnetic material (i.e., surgical clips) implanted electronic infusion pumps or any other conditions that would preclude proximity to a strong magnetic field;
- Are undergoing the MR exam in an emergency situation
- Are pregnant or become pregnant at any point within the study time.
- People with psychiatric disorders will be excluded from the study.
- Are claustrophobic and can not tolerate the imaging.
- Uses supplemental oxygen
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00846573
Start Date
November 1 2008
End Date
April 1 2011
Last Update
November 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMASS Medical School Advanced MRI Center United States
Worcester, Massachusetts, United States